ACST
Companies
NASDAQ
Grace Therapeutics Inc.
Health Care
$3.07
-$0.93 (-23.25%)
Price Chart
Overview
About ACST
acasti pharma, inc., a subsiduary of neptune technologies & bioressources, is a quebec-based biopharmaceutical dedicated in advancing a proprietary portfolio based on marine phospholipids. our products can be used in prescription, medical food and over-the-counter applications, either as a stand-alone, or, as a fixed-dose combination to exisitng productrs, for the prevention and treatment of cardiometabolic disorders.
Market Cap
$28.8M
Volume
237.6K
Avg. Volume
184.6K
P/E Ratio
-2.674603
Dividend Yield
0.00%
Employees
32.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.97
Moderate Correlation
Volatility
High (0.75)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, ACST shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$28.8M
Volume237.6K
P/E Ratio-2.67
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
June 21, 2024Related Securities
Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025